Dyne Therapeutics, Inc. (DYN)
17.11
-0.95
(-5.26%)
USD |
NASDAQ |
Sep 18, 16:00
17.11
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Price : 17.11 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 18.07 | 18.15 | 16.96 | 17.11 | 4.850M |
| Sep 17, 2026 | 17.90 | 18.10 | 17.62 | 18.06 | 2.847M |
| Sep 16, 2026 | 18.37 | 18.37 | 17.09 | 17.30 | 2.156M |
| Sep 15, 2026 | 18.52 | 18.62 | 17.87 | 17.90 | 3.029M |
| Sep 14, 2026 | 18.40 | 19.14 | 18.26 | 18.52 | 3.197M |
| Sep 11, 2026 | 18.59 | 18.74 | 17.94 | 18.21 | 3.774M |
| Sep 10, 2026 | 19.02 | 19.02 | 17.93 | 18.42 | 4.710M |
| Sep 09, 2026 | 19.38 | 20.16 | 18.97 | 19.19 | 5.143M |
| Sep 08, 2026 | 17.08 | 20.91 | 17.00 | 20.31 | 17.17M |
| Sep 04, 2026 | 24.59 | 24.70 | 24.14 | 24.28 | 1.588M |
| Sep 03, 2026 | 25.26 | 25.39 | 24.60 | 24.95 | 1.453M |
| Sep 02, 2026 | 25.55 | 26.18 | 24.92 | 25.14 | 2.181M |
| Sep 01, 2026 | 24.99 | 25.40 | 24.72 | 25.10 | 1.629M |
| Aug 31, 2026 | 24.92 | 25.65 | 24.58 | 25.43 | 2.769M |
| Aug 28, 2026 | 25.82 | 25.98 | 24.83 | 25.07 | 1.187M |
| Aug 27, 2026 | 26.29 | 26.49 | 25.98 | 26.09 | 1.019M |
| Aug 26, 2026 | 26.32 | 26.47 | 25.78 | 26.36 | 1.528M |
| Aug 25, 2026 | 26.28 | 26.69 | 25.96 | 26.34 | 1.459M |
| Aug 24, 2026 | 26.13 | 26.14 | 25.14 | 25.99 | 1.370M |
| Aug 21, 2026 | 26.22 | 26.87 | 26.02 | 26.10 | 1.182M |
| Aug 20, 2026 | 26.33 | 26.43 | 25.68 | 25.98 | 1.484M |
| Aug 19, 2026 | 26.50 | 26.94 | 25.98 | 26.78 | 1.952M |
| Aug 18, 2026 | 25.88 | 26.31 | 25.46 | 26.00 | 1.901M |
| Aug 17, 2026 | 25.90 | 26.43 | 25.30 | 26.15 | 1.318M |
| Aug 14, 2026 | 25.73 | 25.93 | 25.30 | 25.70 | 1.684M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sarepta Therapeutics, Inc. | 20.11 |
| Neurocrine Biosciences, Inc. | 146.23 |
| Recursion Pharmaceuticals, Inc. | 3.83 |
| Agenus, Inc. | 7.85 |
| Amgen, Inc. | 385.65 |
Price Related Metrics
| Price to Book Value | 4.037 |
| Earnings Yield | -19.47% |
| Market Cap | 2.835B |